Fig. 2
From: Correlating COVID-19 severity with biomarker profiles and patient prognosis
Biomarker’s follow-up associated with COVID-19 severity (a) FVIII, reference value 50–150%, (b) VWF, reference value 50–150%, (c) DD, reference value < 500 µg/L FEU. Showing altered plasma levels of key biomarkers after a six month follow-up. (N = 27 FVIII, N = 28 VWF and N = 17 DD). Wilcoxon test; Significant if P < 0.05. *P < 0.05, **P < 0.01, ***P < 0.001.
